• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
The Egyptian Journal of Hospital Medicine
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 99 (2025)
Volume Volume 98 (2025)
Volume Volume 100 (2025)
Volume Volume 97 (2024)
Volume Volume 96 (2024)
Volume Volume 95 (2024)
Volume Volume 94 (2024)
Volume Volume 93 (2023)
Volume Volume 92 (2023)
Volume Volume 91 (2023)
Volume Volume 90 (2023)
Volume Volume 89 (2022)
Volume Volume 88 (2022)
Volume Volume 87 (2022)
Volume Volume 86 (2022)
Volume Volume 85 (2021)
Volume Volume 84 (2021)
Volume Volume 83 (2021)
Volume Volume 82 (2021)
Volume Volume 81 (2020)
Volume Volume 80 (2020)
Volume Volume 79 (2020)
Volume Volume 78 (2020)
Volume Volume 77 (2019)
Volume Volume 76 (2019)
Volume Volume 75 (2019)
Volume Volume 74 (2019)
Volume Volume 73 (2018)
Volume Volume 72 (2018)
Volume Volume 71 (2018)
Volume Volume 70 (2018)
Volume Volume 69 (2017)
Volume Volume 68 (2017)
Volume Volume 67 (2017)
Volume Volume 66 (2017)
Volume Volume 65 (2016)
Volume Volume 64 (2016)
Volume Volume 63 (2016)
Issue Issue 1
Volume Volume 62 (2016)
Volume Volume 61 (2015)
Volume Volume 60 (2015)
Volume Volume 59 (2015)
Volume Volume 58 (2015)
Volume Volume 57 (2014)
Volume Volume 56 (2014)
Volume Volume 55 (2014)
Volume Volume 54 (2014)
Volume Volume 53 (2013)
Volume Volume 52 (2013)
Volume Volume 51 (2013)
Volume Volume 50 (2013)
Volume Volume 49 (2012)
Volume Volume 48 (2012)
Volume Volume 47 (2012)
Volume Volume 46 (2012)
Volume Volume 45 (2011)
Volume Volume 44 (2011)
Volume Volume 43 (2011)
Volume Volume 42 (2011)
Volume Volume 41 (2010)
Volume Volume 40 (2010)
Volume Volume 39 (2010)
Volume Volume 38 (2010)
Volume Volume 37 (2009)
Volume Volume 36 (2009)
Volume Volume 35 (2009)
Volume Volume 34 (2009)
Volume Volume 33 (2008)
Volume Volume 32 (2008)
Volume Volume 31 (2008)
Volume Volume 30 (2008)
Volume Volume 29 (2007)
Volume Volume 28 (2007)
Volume Volume 27 (2007)
Volume Volume 26 (2007)
Volume Volume 25 (2006)
Volume Volume 24 (2006)
Volume Volume 23 (2006)
Volume Volume 22 (2006)
Volume Volume 21 (2005)
Volume Volume 20 (2005)
Volume Volume 19 (2005)
Volume Volume 18 (2005)
Volume Volume 17 (2004)
Volume Volume 16 (2004)
Volume Volume 15 (2004)
Volume Volume 14 (2004)
Volume Volume 13 (2003)
Volume Volume 12 (2003)
Volume Volume 11 (2003)
Volume Volume 10 (2003)
Volume Volume 9 (2002)
Volume Volume 8 (2002)
Volume Volume 7 (2002)
Volume Volume 6 (2002)
Volume Volume 5 (2001)
Volume Volume 4 (2001)
Volume Volume 3 (2001)
Volume Volume 2 (2001)
Volume Volume 1 (2000)
Helal, E., Gewily, D., Al Jalaud, N., Elnemr, G. (2018). Effects of Recovery Period and Stem Cell Enhancer on Bisphenol A Treated Female Albino Rats. The Egyptian Journal of Hospital Medicine, 63(1), 238-247. doi: 10.12816/0023852
Eman G. E. Helal; Doaa I. Gewily; Nora Abdulaziz Al Jalaud; Gamal M. Elnemr. "Effects of Recovery Period and Stem Cell Enhancer on Bisphenol A Treated Female Albino Rats". The Egyptian Journal of Hospital Medicine, 63, 1, 2018, 238-247. doi: 10.12816/0023852
Helal, E., Gewily, D., Al Jalaud, N., Elnemr, G. (2018). 'Effects of Recovery Period and Stem Cell Enhancer on Bisphenol A Treated Female Albino Rats', The Egyptian Journal of Hospital Medicine, 63(1), pp. 238-247. doi: 10.12816/0023852
Helal, E., Gewily, D., Al Jalaud, N., Elnemr, G. Effects of Recovery Period and Stem Cell Enhancer on Bisphenol A Treated Female Albino Rats. The Egyptian Journal of Hospital Medicine, 2018; 63(1): 238-247. doi: 10.12816/0023852

Effects of Recovery Period and Stem Cell Enhancer on Bisphenol A Treated Female Albino Rats

Article 14, Volume 63, Issue 1, April 2016, Page 238-247  XML PDF (338.26 K)
Document Type: Original Article
DOI: 10.12816/0023852
View on SCiNiTO View on SCiNiTO
Authors
Eman G. E. Helal1; Doaa I. Gewily1; Nora Abdulaziz Al Jalaud2; Gamal M. Elnemr3
1Department of Zoology, Faculty of Science (Girls), Al-Azhar University, Cairo, Egypt,
2Department of Biology, Faculty of Science, University of Dammam, Saudi Arabia
3Department of Medical and Radiological Researches, Nuclear Materials Authority, Egypt
Abstract
Background: Bisphenol A (BPA) is a worldwide used endocrine disruptor that is incorporated in many plastic industries. Exposure of humans to such substance starts early during the fetal life, postnatal life, and extends throughout the life of the individual. Many agencies raised warnings against excessive use of such substance.
Aim of the work: This study aimed to investigate effects of the recovery period (RP) and stem cell enhancer (SCE) on the female albino rats which received BPA.
Materials and Methods: This study was performed on forty female albino rats with an average body weight of 140-160 grams. Animals were divided into four groups (10 rats per cage); group I (control untreated for 30 days), group II (BPA treated for 15 days, and then sacrificed), group III (BPA treated first for 15 days, then left for another 15 days without any treatment “RP”), and group IV (BPA treated first for 15 days, then treated with SCE for another 15 days). The following biochemical analyses were done to all groups; ALT (alanine amino-transferase), AST (aspartate amino-transferase), GGT (gamma glutamyl-transferase), total proteins, albumin, globulins, A/G ratio [i.e., liver function tests], creatinine, A/C (albumin/creatinine) ratio, uric acid [i.e., renal function tests], total lipids, total cholesterol, LDL-C (low density lipoprotein cholesterol), HDL-C (high density lipoprotein cholesterol), and triglycerides [i.e., lipids profile].
Results: In the BPA treated rats (group II) the biochemical results showed highly significant increases (P<0.01) in the enzymatic activities of ALT, AST, GGT, creatinine, uric acid, total lipids, total cholesterol, LDL-C, and triglycerides levels, with only a significant increase (P<0.05) in globulins levels when compared to the control group. On the other hand, there was highly significant decreases (P<0.01) in total proteins, albumin, A/G ratio, A/C ratio, and HDL-C levels when compared to the control group. These results turned back to about the normal control values after stopping the use of BPA and either taking a RP (group III) or receiving the SCE (group IV).
Conclusions and Recommendations: It could be concluded that BPA has dangerous toxic effects on the liver and kidney functions as well as on the lipids profile. So, we recommend minimizing utilization of this compound (BPA) as possible to protect people from these hazardous effects. Moreover, the RP (i.e., 15 days without treatment) is better than the use of SCE which has no more benefit against the antitoxic effects of BPA.
 
Keywords
BPA; bisphenol A, RP; recovery period, SCE; Stem Cell Enhancer
Statistics
Article View: 243
PDF Download: 383
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.